{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:20:56Z","timestamp":1789716056677,"version":"4.0.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10,23]]},"DOI":"10.1097\/qad.0b013e32834b3629","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T04:14:48Z","timestamp":1312258488000},"page":"1971-1979","source":"Crossref","is-referenced-by-count":39,"title":["Colorectal microbicide design"],"prefix":"10.1097","volume":"25","author":[{"given":"Carolina","family":"Herrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Cranage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Shattock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210130","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1258\/095646202760326426","article-title":"HIV transmission risk behaviours among HIV-positive persons in serodiscordant relationships.","volume":"13","author":"Kalichman","year":"2002","journal-title":"Int J STD AIDS"},{"key":"R2-5-20210130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/oxfordjournals.aje.a009564","article-title":"Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV.","volume":"148","author":"Leynaert","year":"1998","journal-title":"Am J Epidemiol"},{"key":"R3-5-20210130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/oxfordjournals.aje.a009276","article-title":"Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study.","volume":"146","author":"Padian","year":"1997","journal-title":"Am J Epidemiol"},{"key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/oxfordjournals.aje.a010003","article-title":"Per-contact risk of human immunodeficiency virus transmission between male sexual partners.","volume":"150","author":"Vittinghoff","year":"1999","journal-title":"Am J Epidemiol"},{"key":"R5-5-20210130","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/00002030-200008180-00011","article-title":"Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue.","volume":"14","author":"Anton","year":"2000","journal-title":"AIDS"},{"key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1202::AID-IMMU1202>3.0.CO;2-O","article-title":"Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection.","volume":"29","author":"Lapenta","year":"1999","journal-title":"Eur J Immunol"},{"key":"R7-5-20210130","doi-asserted-by":"crossref","first-page":"8390","DOI":"10.1128\/JVI.75.18.8390-8399.2001","article-title":"A preponderance of CCR5() CXCR4() mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection.","volume":"75","author":"Poles","year":"2001","journal-title":"J Virol"},{"key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"e1000890","DOI":"10.1371\/journal.ppat.1000890","article-title":"High multiplicity infection by HIV-1 in men who have sex with men.","volume":"6","author":"Li","year":"2010","journal-title":"PLoS Pathog"},{"key":"R9-5-20210130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev.med.59.061206.112737","article-title":"Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission.","volume":"59","author":"Klasse","year":"2008","journal-title":"Annu Rev Med"},{"key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/QCO.0b013e328334fe70","article-title":"Microbicides for HIV prevention: reality or hope.","volume":"23","author":"McGowan","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"R11-5-20210130","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"R12-5-20210130","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s10461-009-9611-5","article-title":"Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men.","volume":"14","author":"Ventuneac","year":"2010","journal-title":"AIDS Behav"},{"key":"R14-5-20210130","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1371\/journal.pmed.0050157","article-title":"Prevention of SIV rectal transmission and priming of T cell responses in macaques after local preexposure application of tenofovir gel.","volume":"5","author":"Cranage","year":"2008","journal-title":"PLoS Med"},{"key":"R15-5-20210130","first-page":"S133","article-title":"Prevalence of mutations associated with antiretroviral drug resistance among men and women newly diagnosed with HIV in 10 US cities, 1997-2001.","volume":"8","author":"Bennett","year":"2003","journal-title":"Antiviral Ther"},{"key":"R16-5-20210130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00126334-200102010-00006","article-title":"Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid.","volume":"26","author":"Briones","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-5-20210130","first-page":"S137","article-title":"French National Sentinel Survey of antiretroviral resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.","volume":"8","author":"Chaix","year":"2003","journal-title":"Antiviral Ther"},{"key":"R18-5-20210130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00126334-200103010-00010","article-title":"Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study.","volume":"26","author":"Duwe","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-5-20210130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMoa013552","article-title":"Antiretroviral-drug resistance among patients recently infected with HIV.","volume":"347","author":"Little","year":"2002","journal-title":"N Engl J Med"},{"key":"R20-5-20210130","first-page":"S144","article-title":"Evidence for a different transmission efficiency of viruses with distinct drug-resistance genotypes.","volume":"8","author":"Mendoza","year":"2003","journal-title":"Antiviral Ther"},{"key":"R21-5-20210130","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1097\/00002030-200001280-00003","article-title":"Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.","volume":"14","author":"Salomon","year":"2000","journal-title":"AIDS"},{"key":"R22-5-20210130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/bmj.322.7294.1087","article-title":"Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom.","volume":"322","year":"2001","journal-title":"BMJ"},{"key":"R23-5-20210130","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1128\/AAC.01096-08","article-title":"Reverse transcriptase inhibitors as potential colorectal microbicides.","volume":"53","author":"Herrera","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-5-20210130","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1128\/JVI.74.18.8358-8367.2000","article-title":"Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.","volume":"74","author":"Derdeyn","year":"2000","journal-title":"J Virol"},{"key":"R25-5-20210130","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","article-title":"Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.","volume":"72","author":"Platt","year":"1998","journal-title":"J Virol"},{"key":"R26-5-20210130","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-5-20210130","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1128\/JVI.66.11.6587-6600.1992","article-title":"Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation.","volume":"66","author":"Li","year":"1992","journal-title":"J Virol"},{"key":"R28-5-20210130","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1128\/JVI.65.8.3973-3985.1991","article-title":"Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes.","volume":"65","author":"Li","year":"1991","journal-title":"J Virol"},{"key":"R29-5-20210130","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1128\/JVI.65.9.4887-4892.1991","article-title":"Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors.","volume":"65","author":"Nunberg","year":"1991","journal-title":"J Virol"},{"key":"R30-5-20210130","first-page":"42","article-title":"Most multidrug-resistant HIV-1 reverse transcriptase clones in plasma encode functional reverse transcriptase enzymes.","volume":"6","author":"Dupnik","year":"2001","journal-title":"Antiviral Ther"},{"key":"R31-5-20210130","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/JVI.73.1.684-694.1999","article-title":"Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion.","volume":"73","author":"Gordon","year":"1999","journal-title":"J Virol"},{"key":"R32-5-20210130","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/01.aids.0000232230.96134.80","article-title":"Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides.","volume":"20","author":"Fletcher","year":"2006","journal-title":"AIDS"},{"key":"R33-5-20210130","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1371\/journal.pmed.0030351","article-title":"Which topical microbicides for blocking HIV-1 transmission will work in the real world.","volume":"3","author":"Klasse","year":"2006","journal-title":"PLoS Med"},{"key":"R34-5-20210130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nprot.2008.245","article-title":"Use of human tissue explants to study human infectious agents.","volume":"4","author":"Grivel","year":"2009","journal-title":"Nat Protoc"},{"key":"R36-5-20210130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrmicro729","article-title":"Inhibiting sexual transmission of HIV-1 infection.","volume":"1","author":"Shattock","year":"2003","journal-title":"Nat Rev Microbiol"},{"key":"R37-5-20210130","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1371\/journal.ppat.0020119","article-title":"Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol.","volume":"2","author":"Figueiredo","year":"2006","journal-title":"PLoS Pathog"},{"key":"R38-5-20210130","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1021\/bi00120a013","article-title":"The observed inhibitory potency of 3-azido-3-deoxythymidine 5-triphosphate for HIV-1 reverse transcriptase depends on the length of the poly(rA) region of the template.","volume":"31","author":"Ma","year":"1992","journal-title":"Biochemistry"},{"key":"R39-5-20210130","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1128\/JVI.73.8.6700-6707.1999","article-title":"Reverse transcriptase inhibitors can selectively block the synthesis of differently sized viral DNA transcripts in cells acutely infected with human immunodeficiency virus type 1.","volume":"73","author":"Quan","year":"1999","journal-title":"J Virol"},{"key":"R40-5-20210130","doi-asserted-by":"crossref","first-page":"13223","DOI":"10.1021\/bi970852k","article-title":"Synergistic inhibition of HIV-1 reverse transcriptase by combinations of chain-terminating nucleotides.","volume":"36","author":"Villahermosa","year":"1997","journal-title":"Biochemistry"},{"key":"R41-5-20210130","doi-asserted-by":"crossref","first-page":"e9310","DOI":"10.1371\/journal.pone.0009310","article-title":"In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.","volume":"5","author":"Rohan","year":"2010","journal-title":"PLoS One"},{"key":"R42-5-20210130","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1128\/AAC.00816-06","article-title":"In vitro human immunodeficiency virus type 1 resistance selections with combinations of tenofovir and emtricitabine or abacavir and lamivudine.","volume":"50","author":"Margot","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R43-5-20210130","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/00126334-200411010-00002","article-title":"Patterns of resistance emerging in HIV-1 from antiretroviral-experienced patients undergoing intensification therapy with tenofovir disoproxil fumarate.","volume":"37","author":"McColl","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R44-5-20210130","first-page":"S151","article-title":"Characterization of resistance mutation patterns emerging over 2 years during first-line antiretroviral treatment with tenofovir DF or stavudine in combination with lamivudine and efavirenz.","volume":"8","author":"Miller","year":"2003","journal-title":"Antiviral Therapy"},{"key":"R45-5-20210130","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1097\/00002030-200212060-00003","article-title":"The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses.","volume":"16","author":"Wei","year":"2002","journal-title":"AIDS"},{"key":"R46-5-20210130","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.46.11.3437-3446.2002","article-title":"Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65RM184V and their effects on enzyme function and viral replication capacity.","volume":"46","author":"White","year":"2002","journal-title":"Antimicrob Agents Chemother"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201110230-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:21:26Z","timestamp":1786047686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201110230-00005"}},"subtitle":["triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants"],"short-title":[],"issued":{"date-parts":[[2011,10,23]]},"references-count":44,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32834b3629","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10,23]]}}}